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Abstract: Four-way junctions (4WJs) are supramolecular
DNA assemblies comprising four interacting DNA strands
that in biology are involved in DNA-damage repair. In this
study, a new mononuclear platinum(II) complex 1 was
prepared that is capable of driving the crystallization of the
DNA oligomer 5’-d(CGTACG)-3’ specifically into a 4WJ-like
motif. In the crystal structure of the 1–CGTACG adduct, the
distorted-square-planar platinum complex binds to the core of
the 4WJ-like motif through p–p stacking and hydrogen
bonding, without forming any platinum–nitrogen coordination
bonds. Our observations suggest that the specific molecular
properties of the metal complex are crucially responsible for
triggering the selective assembly of this peculiar DNA super-
structure.
Interactions between platinum-based compounds and
nucleic acids have been extensively studied because the
widely used anticancer drugs cisplatin, oxaliplatin, and
carboplatin bind tightly to nuclear DNA, which is also
reputed to be their primary target.[1] Indeed, following the
hydrolysis of two cis Pt@Cl bonds, cisplatin typically forms
two coordination bonds with nitrogen atoms of adjacent DNA
base pairs, thus producing local DNA damage, which initiates
cancer-cell death.[2] Many cytotoxic aromatic compounds,
whether they contain platinum or not, interact with DNA by
intercalation of their flat, aromatic rings into the p–p stacked
DNA base pairs of double-stranded DNA. Overall, the
development of molecules of different shapes, coordination
and supramolecular properties, that recognize or induce the
formation of different types of DNA motifs is an active field
of research: trans platinum compounds,[3] compounds that
interact with the sugar phosphate backbone of DNA,[4] and
those that recognize nucleic acid superstructures that are
different from double-stranded DNA, such as DNA mis-
matches,[5] G-quadruplexes,[6] DNA bulges,[7] viral RNAs,[8]
and three-way junctions, have been extensively studied.[9] In
particular, binuclear metal complexes developed by the
Hannon group,[10] which recognize three-way junctions, have
attracted considerable attention in the last decade. This series
of supramolecular cylinders interact with the DNA palin-
dromic hexanucleotide 5’-d(CGTACG)-3’ to form three-way
junctions with the metal complex in the central hydrophobic
cavity of the DNA assembly.[11] A later study demonstrated
the ability of RNA three-way junctions, such as 5’-CGUACG-
3’, to also interact specifically with these metal complexes.[12]
Four-way junctions (4WJs) are another form of non-
canonical DNA superstructures characterized by four inter-
connected DNA fragments. Many supramolecular isomers of
these highly flexible assemblies have been described. Some of
these isomers, called Holliday junctions (HJs), are biologi-
cally important as they are involved in DNA repair.[13]
Processes such as double HJ dissolution are crucial for
suppressing specific DNA damage that otherwise causes
cancer predisposition and/or premature ageing, for example,
in Bloom syndrome.[14] HJs have even been proposed as
a target for the design of selective inhibitors of HJ resolution,
which would benefit from compounds capable of stabilizing
4WJs. The first structural characterization of a 4WJ was
reported in 1999 with the sequence 5’-d(CCGGGACCGG)-
3’.[15] Since then, several protein–4WJ interactions have been
characterized,[16] and two crystal structures of 4WJs interact-
ing with small organic molecules have been published.[17] We
now report the induction of a 4WJ-like DNA structure by
a new mononuclear platinum compound, [Pt(H2bapbpy)]-
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(PF6)2 (1, in which H2bapbpy is N-(6-(6-(pyridin-2-ylamino)-
pyridin-2-yl)pyridin-2-yl)pyridin-2-amine).
Complex 1 was synthesized in 75% yield by heating the
tetrapyridyl ligand H2bapbpy
[18] with K2PtCl4 in an ethanol–
water mixture. Single crystals suitable for X-ray crystal-
structure determination were obtained from acetonitrile. In
the crystal structure of [Pt(Hbapbpy)]PF6 (Figure 1; see also
Table S1 in the Supporting Information), the d8 metal
complex shows a strongly distorted, helical square-planar
coordination, similar to that observed in octahedral iron(II)
complexes of the same ligand.[18] In contrast to previously
described octahedral metal complexes of this ligand, however,
in 1 the H2bapbpy ligand
was clearly deprotonated,
thus indicating that the
protons borne by the non-
coordinating NH bridges
of the ligand become
quite acidic upon
platinum(II) coordination.
In solution, deprotonation
of these NH bridges
(pKa1= 8.3; see Figure S1
in the Supporting Informa-
tion) can interconvert the
metal complex between its
monocationic ([Pt-
(Hbapbpy)]+) and dicat-
ionic ([Pt(H2bapbpy)]
2+)
forms, and under neutral
conditions the complex is
mostly in the dicationic
state. Owing to the tetra-
dentate nature of the
H2bapbpy ligand and the
square-planar preferred
geometry of d8 metal cen-
ters, the coordination
sphere of platinum in 1 is
saturated and very stable.
Stability studies in water,
phosphate buffer, and cell
growth medium, showed
that over 48 h only depro-
tonation occurred, that is, no hydrolysis took place (see
Figure S2).
When 1 was added to a solution of the palindromic
hexanucleotide 5’-d(CGTACG)-3’, single crystals of an
adduct 1–CGTACG were grown that could be subjected to
crystal-structure determination. The 1–CGTACG adduct
crystallized in the P3221 space group (see Table S2). The
asymmetric unit shows one molecule of 1 per four DNA
strands. The four crystallographically independent DNA
strands form pairs of B-type double-helix units (Figure 2a)
that stack on each other to form columns growing in the [110],
[010], and [100] crystal directions. The 5’-terminal cytosines
C1A and C1C were not localized, whereas C7B and C7D
protrude out from the helix and form a connection with an
adjacent symmetry-related column in the packing structure.
No coordination was found between the DNA base pairs and
the platinum atom, which remained coordinated to the four
nitrogen atoms of the tetrapyridyl ligand. The DNA-binding
site of 1 is located at the interface between couples of B-type
helices in each DNA column, where the C7 cytosine residues
are twisted away. Although the “almost flat”, aromatic
structure of 1 made us initially expect simple intercalation
between the DNA base pairs, the binding site of 1 unexpect-
edly led to a remarkable distortion of the double-helix
structures (the rotational parameters of the base pairs are
shown in Table S3).[19] The resulting noncanonical binding site
is formed by two tetrads (the two gray rectangles shown in
Figure 1. Displacement ellipsoid plot (50% probability level) of the
cationic moiety [Pt(Hbapbpy)]+ as observed in the crystal structure of
[Pt(Hbapbpy)]PF6. Counteranions have been omitted for clarity.
[21]
Figure 2. Crystal structure of the adduct 1–CGTACG. a) B-Type double-helix units arranged in a column in
which each B-type double-helix unit is formed by two contiguous ds-CGTACG moieties. Complex 1 is shown in
CPK style. b, c) Binding site of the platinum complex 1 in the 1-F and 1-G conformation, respectively (see text).
The four colours red, blue, green, and pink of the DNA strands correspond to the four crystallographically
independent DNA oligomers (denoted A–D).
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Figure 3a in each column), which sandwich the metal com-
plex through p–p stacking. Each tetrad is built up of two C–G
pairs formed with the contribution of a cytosine residue from
the symmetry-related column (C5A–G8B and G6C–C7B;
G6A–C7D and C5C–G8D). The two C–G pairs are then
connected by a double N2@H···N3 hydrogen bond established
by the G6 and G8 guanine residues. Notably, the connections
provided by C7B and C7D result overall in a 4WJ-like
structure (Figure 3a,b).
Despite the significant differences characterizing the 6-
mer DNA sequence used in the study with respect to longer
sequences found to generate real HJs, in the structure of 1–
CGTACG the binding site of the platinum complex was found
precisely at this 4WJ connection. The nonclassical intercala-
tion site hosts one platinum complex, which was found to be
at two equally occupied positions, with the platinum centers
about 2.5c from each other. The best results in terms of
B factors and residual densities in the Fo–Fc maps, which were
affected by low resolution of diffraction and twinning of the
crystals, were obtained by introducing two different confor-
mations of the complex in the model, indicated below as 1-F
and 1-G (Figure 2b,c). At the end of refinement, the two
molecules of 1 were found to be helical enantiomers. The two
molecules were in an almost coplanar arrangement and
approximately rotated by about 908 with respect to each other
about the helical axis (see Figure S3). The presence of two
equally probable positions for 1 in the 4WJ is most likely
possible because the main interaction of the complex with the
DNA bases is p–p stacking, with mean interplanar distances
of about 3.4c for both conformations, so that the different
chirality does not introduce any destabilization. Besides p–p
stacking, coulombic interactions between the positively
charged platinum complexes and the negative electron
density of DNA must play a role in the stabilization of the
adduct as well, whereas the protonation state of the amine
bridges of the tetrapyridyl ligands could not be determined
crystallographically.
To obtain a more detailed view of the interactions taking
place between the two twisted molecules of 1 and the DNA
4WJ-like structure, we performed quantummechanics/molec-
ular mechanics (QM/MM) calculations starting from the
crystallographic coordinates of both conformations 1-F and 1-
G. Overall, in silico relaxation did not lead to significant
variations of the conformation of the model (see Figures S4
and S5) as compared to that of the crystal structure (Fig-
ure 4a,b). Interestingly, the model clearly suggests that one of
the two noncoordinating amines of the H2bapbpy ligand of
complex 1 may be engaged in H-bonding with DNA;
however, the corresponding N···O contacts from the XRD
analysis were too long (2.6–4.1c) to conclude that a strong
H-bond interaction was present considering the insufficient
quality of the electron-density map for that level of descrip-
tion.
The unique structure of the 1–CGTACG adduct prompted
us to test the antiproliferative activity of 1 in cancer cell lines,
and its ability to reach the cell nucleus. The cancer cell growth
inhibition concentration (IC50) of 1 was investigated in two
cisplatin-sensitive cancer cell lines (A549, MCF-7), one
Figure 3. Different views of the four-way-junction DNA arrangement in
the crystal structure of 1–CGTACG. a) Base-pair arrangement and
hydrogen-bonding interactions. Complex 1 is not shown; the binding
site in each column is shown as two gray rectangles. The C1A and C1C
residues, not localized in the electron-density map, are represented by
empty (not colored) ribose rings. b) “X” conformation and 5’ and 3’
DNA growth directions; the two molecules of 1 are shown as a CPK
model (only conformer F is shown for clarity).
Figure 4. Binding site and selected interactions from QM/MM calcu-
lations for a) complex 1-F and b) complex 1-G. Carbon atoms of
residues in the main column are shown in green, and carbon atoms of
residues of symmetry-related columns in brown.
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cisplatin-resistant cancer cell line (MDA-MB231), and one
nonmalignant lung cell line (MRC-5) by using a previously
reported protocol.[20] IC50 values as low as or much lower than
that of cisplatin were found, also in noncancerous MRC-5
cells (Table 1). The high toxicity of 1 in cisplatin-resistant
MDA-MB231 cancer cells suggests a different mode of action
(MoA) of 1 as compared to cisplatin. The uptake and
localization of 1 in the cytosol, membranes, nuclei, and
cytoskeleton of A549 cells were determined 24 h after
treatment at 1.0 mm by cell fractionation followed by ICP-
MS analysis (see Table S4). Of the total uptake of 1586 pmol
Pt per million cells, 15% of the metal was found in the
nucleus, similarly to cisplatin (14%). When 1 was incubated
for 24 h with a 2686 bp pUC19 plasmid, very weak inter-
actions were observed at a 20:1 base pair/metal complex ratio,
but at a 7.5:1 or lower ratio, migration of the supercoiled
plasmid was severely retarded (see Figure S6). Such retarda-
tion implies that 1 does indeed interact with pUC19 plasmid
DNA, but we cannot discriminate, at this stage, between
specific interaction of 1 with the 4WJ in solution, and
nonspecific interaction with dsDNA.
In conclusion, 1 is the first example of a metal complex
capable of inducing a noncanonical DNA structure resem-
bling a 4WJ in the DNA palindromic hexanucleotide 5’-
d(CGTACG). Details of the interaction have been elucidated
at the atomic level. At present, the exact role of the distorted
conformation of 1 and its noncoordinated NH bridges in the
stabilization of the 4WJ-like structure still needs to be
assessed. Our preliminary biological results show that 1 has
high biological activity and, because it goes to the nuclei, that
it can interact with nuclear DNA. However, at this stage we
can by no means assess whether the 4WJ-like DNA structure
observed in the solid state also forms in solution (see
Figure S7), and whether it is responsible for the toxicity of
1. Meanwhile, the fact that the DNA 6-mer used in our study
is identical to that used by Hannon and co-workers to
demonstrate the specific interaction of DNA three-way
junctions with dinuclear compounds[11a] opens fascinating
perspectives, as the same DNA sequence is triggered to adopt
different three-dimensional conformations depending on the
nature of the interacting metal complex. Chemically speak-
ing, the results reported herein suggest that it may be possible
to design compounds with specific molecular shapes that
develop selective supramolecular interactions with DNA,
thus leading to the self-assembly of different DNA super-
structures. Overall, understanding the link between the
specific shape and supramolecular properties of 1, and its
unique ability to drive the crystallization of a DNA 4WJ-like
structure, may lead to unforeseen applications in supramolec-
ular chemistry, biosensing, and/or medicinal chemistry.
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